|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Surgery, East Tennessee State University, Johnson City, Tennessee, United States
2 Animal Model Research Center, Nanjing University, Nnajing, Jiangsu, China
3 Internal Medicine, East Tennessee State University, Johnson City, Tennessee, United States
4 Section of Medical Education, East Tennessee State University, Nanjing, Tennessee, United States
* To whom correspondence should be addressed. E-mail: li{at}etsu.edu.
Myocardial dysfunction is a major consequence of septic shock and contributes to the high mortality of sepsis. We have previously reported that glucan phosphate (GP) significantly increased survival in a murine model of cecal ligation and puncture (CLP)-induced sepsis. In the present study, we examined the effect of GP on cardiac dysfunction in CLP-induced septic mice. GP was administered to ICR/HSD mice 1 hr before induction of CLP. Sham surgical operated mice served as control. Cardiac function was significantly decreased six hrs after CLP-induced sepsis compared with sham control. In contrast, GP administration prevented CLP-induced cardiac dysfunction. Macrophage migration inhibitory factor (MIF) has been implicated as a major factor in cardiomyocyte apoptosis and cardiac dysfunction during septic shock. CLP increased myocardial MIF expression by 88.3% (p<0.05) and cardiomyocyte apoptosis by 7.8 fold (p<0.05) compared with sham control. GP administration, however, prevented CLP-increased MIF expression, and decreased cardiomyocyte apoptosis by 51.2% (p<0.05) compared with untreated CLP mice. GP also prevented sepsis-caused decreases in phospho-Akt, phospho-GSK-3
and Bcl-2 levels in the myocardium of septic mice. These data suggest that GP treatment attenuates cardiovascular dysfunction in fulminating sepsis. GP administration also activates the PI3K/Akt pathway, decreases myocardial MIF expression and reduces cardiomyocyte apoptosis.
This article has been cited by other articles:
![]() |
T. Ha, F. Hua, X. Liu, J. Ma, J. R. McMullen, T. Shioi, S. Izumo, J. Kelley, X. Gao, W. Browder, et al. Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism Cardiovasc Res, June 1, 2008; 78(3): 546 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zernecke, J. Bernhagen, and C. Weber Macrophage Migration Inhibitory Factor in Cardiovascular Disease Circulation, March 25, 2008; 117(12): 1594 - 1602. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |